Timothy A. Springer - Sep 24, 2024 Form 4 Insider Report for Tectonic Therapeutic, Inc. (TECX)

Signature
/s/ Daniel Lochner, Attorney-in-Fact
Stock symbol
TECX
Transactions as of
Sep 24, 2024
Transactions value $
$1,440,829
Form type
4
Date filed
9/26/2024, 06:15 PM
Previous filing
Aug 20, 2024
Next filing
Sep 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECX Common Stock Other $0 -1.24M -80% $0.00 310K Sep 24, 2024 By LLC F1, F2
transaction TECX Common Stock Other $0 +1.05M +39.18% $0.00 3.75M Sep 24, 2024 Direct F3
transaction TECX Common Stock Other $0 +186K $0.00 186K Sep 24, 2024 By Spouse F3
transaction TECX Common Stock Purchase $691K +24.5K +0.65% $28.16 3.77M Sep 26, 2024 Direct F4
transaction TECX Common Stock Purchase $553K +19K +0.5% $29.13 3.79M Sep 26, 2024 Direct F5
transaction TECX Common Stock Purchase $123K +4.07K +0.11% $30.10 3.79M Sep 26, 2024 Direct F6
transaction TECX Common Stock Purchase $74.1K +2.4K +0.06% $30.87 3.8M Sep 26, 2024 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a distribution in kind, for no additional consideration, by TAS Partners, LLC ("TAS") to the Reporting Person and his spouse.
F2 These shares are held by TAS. The Reporting Person is the sole managing member of TAS and, as such, has sole voting and dispositive power over the shares held by TAS. The Reporting Person disclaims beneficial ownership of the shares held by TAS except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3 Represents the acquisition of the shares from TAS, as more specifically described in Footnote (1) herein.
F4 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $27.68 to $28.66 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $28.69 to $29.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $29.75 to $30.63 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F7 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $30.80 to $30.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.